Dainippon to buy U.S. bio-venture in cancer-drug push (Reuters)

[unable to retrieve full-text content]Reuters - Japan's Dainippon Sumitomo Pharma Co said on Wednesday that it will buy U.S.-based Boston Biomedical Inc for $200 million to expand its cancer treatment business and extend its global reach.

Source: http://us.rd.yahoo.com/dailynews/rss/diseases/*http%3A//news.yahoo.com/s/nm/20120229/hl_nm/us_dainipponsumitomo

david stern julian beever appeasement ian stewart ian stewart odom colt mccoy